Systematic Review and Meta‐analysis on the Incidence of Level‐Specific Cervical Nodal Metastasis in Primary Parotid Malignancies
Otolaryngology–Head and Neck Surgery · 2023
DOI: 10.1002/ohn.207 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2023. Verfasst von Joyce Pui Kiu Ho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, John Hunter Hospital, New Lambton Heights, New South Wales, Australia. Hauptthemen laut MEDLINE: Parotid Neoplasms, Carcinoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Objective
In primary parotid gland malignancies, the incidence of level‐specific cervical lymph node metastasis in clinically node‐positive necks remains unclear. This study aimed to determine the incidence of level‐specific cervical node metastasis in clinically node‐negative (cN0) and node‐positive (cN+) patients who presented with primary parotid malignancies. Data Sources Electronic databases (MEDLINE, EMBASE, PubMed, Cochrane). Review Methods Random‐effects meta‐analysis was used to calculate pooled estimate incidence of level‐specific nodal metastasis for parotid malignancies with 95% confidence intervals (CIs). Subgroup analyses of cN0 and cN+ were performed.
Results
Thirteen publications consisting of 818 patients were included. The overall incidence of cervical nodal involvement in all neck dissections was 47% (95% CI, 31%‐63%). Among those who were cN+, the incidence of nodal positivity was 89% (95% CI, 75%‐98%). Those who were cN0 had an incidence of 32% (95% CI, 14%‐53%). In cN+ patients, the incidence of nodal metastasis was high at all levels (level I 33%, level II 73%, level III 48%, level IV 39%, and level V 37%). In cN0 patients, the incidence of nodal metastasis was highest at levels II (28%) and III (11%).
Conclusion
For primary parotid malignancies, the incidence of occult metastases was 32% compared to 89% in a clinically positive neck. It is recommended that individuals with a primary parotid malignancy requiring elective treatment of the neck have a selective neck dissection which involves levels II to III, with the inclusion of level IV based on clinical judgment. Those undergoing a therapeutic neck dissection should undergo a comprehensive neck dissection (levels I‐V).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
- Department of Oral and Maxillofacial Surgery, John Hunter Hospital, New Lambton Heights, New South Wales, Australia.
ORCID-Profile: Joyce Pui Kiu Ho
Zitieren
APA
Ho, J. P. K., Mair, M., Noor, A., Fuzi, J., Giles, M., Ludbrook, I., Hoffman, G., Winters, R., Cope, D., & Eisenberg, R. (2023). Systematic Review and Meta‐analysis on the Incidence of Level‐Specific Cervical Nodal Metastasis in Primary Parotid Malignancies. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.207
Vancouver
Ho JPK, Mair M, Noor A, Fuzi J, Giles M, Ludbrook I, et al. Systematic Review and Meta‐analysis on the Incidence of Level‐Specific Cervical Nodal Metastasis in Primary Parotid Malignancies. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.207
BibTeX
@article{Ho2023,
author = {Ho, Joyce Pui Kiu and Mair, Manish and Noor, Anthony and Fuzi, Jordan and Giles, Mitchell and Ludbrook, Isabella and Hoffman, Gary and Winters, Ryan and Cope, Daron and Eisenberg, Robert},
title = {Systematic Review and Meta‐analysis on the Incidence of Level‐Specific Cervical Nodal Metastasis in Primary Parotid Malignancies},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2023},
doi = {10.1002/ohn.207}
}
EUVIMED